Sensitivity of Quantitative Metrics Derived from DCE MRI and a Pharmacokinetic Model to Image Quality and Acquisition Parameters

Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results

Hope S. Rugo, Roy S. Herbst, Glenn Liu et al. · Journal of Clinical Oncology · 2005 · 485 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Delay and dispersion effects in dynamic susceptibility contrast MRI: Simulations using singular value decomposition

Fernando Calamante, David G. Gadian, Alan Connelly · Magnetic Resonance in Medicine · 2000 · 454 citations · Full text

Natural Sciences, Bioengineering, Biomedical Engineering +14

A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients

A. Gregory Sorensen, Tracy T. Batchelor, Weiting Zhang et al. · Cancer Research · 2009 · 391 citations

Medicine, Oncology, Pharmacotherapy +17

Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis

Susan Galbraith, Martin A. Lodge, N. Jane Taylor et al. · NMR in Biomedicine · 2002 · 340 citations · Full text

Medicine, Oncology, Radiology +15

Temporal sampling requirements for the tracer kinetics modeling of breast disease

Elizabeth Henderson, Brian K. Rutt, Ting‐Yim Lee · Magnetic Resonance Imaging · 1998 · 260 citations

Natural Sciences, Biomedical Sciences, Pharmacokinetics +13